Timken director awarded 2,270 company shares
Timken Co director Maria A. Crowe reported an equity award of 2,270 shares of Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Timken Co director Maria A. Crowe reported an equity award of 2,270 shares of Common Stock. The Form 4 shows the shares were acquired at a price of $0.00 per share as a compensation-related grant. A footnote explains this reflects vesting of 100% of time-based restricted share units granted on May 2, 2025. Following this vesting, Crowe directly holds 29,936 Timken shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,270 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents vesting of 100% of the time-based restricted share units granted on May 2, 2025.
Key Figures
Key Terms
vesting financial
grant, award, or other acquisition financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Timken (TKR) director Maria Crowe report?
Is Maria Crowe’s Timken (TKR) Form 4 transaction a stock purchase or sale?
Does the Timken (TKR) Form 4 mention any derivative securities for Maria Crowe?
AI-generated analysis. How Rhea-AI works. Not financial advice.